{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:13:39Z","timestamp":1791980019475,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jtha.2025.11.024","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T17:14:42Z","timestamp":1766164482000},"page":"1032-1041","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai Venous Thromboembolism Cancer trial"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5256-6346","authenticated-orcid":false,"given":"Nick","family":"van Es","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk J.J.","family":"Scheres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen M.","family":"Sanfilippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"B\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Di Nisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D.","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Redfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelise","family":"Segers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Verhamme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Siegal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.11.024_bib1","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1111\/jth.15787","article-title":"Identification of outcomes in clinical studies of interventions for venous thromboembolism in non-pregnant adults: a scoping review","volume":"20","author":"Tritschler","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.024_bib2","series-title":"Users\u2019 guides to the medical literature: a manual for evidence-based clinical practice","article-title":"Composite end points","author":"Ferreira-Gonz\u00e1lez","year":"2015"},{"key":"10.1016\/j.jtha.2025.11.024_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCULATIONAHA.113.006588","article-title":"Rethinking composite end points in clinical trials: insights from patients and trialists","volume":"130","author":"Stolker","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.11.024_bib4","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/eurheartj\/ehr352","article-title":"The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities","volume":"33","author":"Pocock","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.024_bib5","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/s41591-024-02941-8","article-title":"A hierarchical kidney outcome using win statistics in patients with heart failure from the DAPA-HF and DELIVER trials","volume":"30","author":"Kondo","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jtha.2025.11.024_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jchf.2020.02.010","article-title":"Use of the win ratio in cardiovascular trials","volume":"8","author":"Ferreira","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jtha.2025.11.024_bib7","first-page":"2171","article-title":"Results of the COMPASS trial analyzed using win ratio compared with conventional analytic approaches","volume":"40","author":"Eikelboom","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jtha.2025.11.024_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1160\/TH15-06-0452","article-title":"Edoxaban for treatment of venous thromboembolism in patients with cancer: rationale and design of the Hokusai VTE-cancer study","volume":"114","author":"van Es","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.024_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.024_bib10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.11.024_bib11","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/sim.8967","article-title":"Win odds: an adaptation of the win ratio to include ties","volume":"40","author":"Brunner","year":"2021","journal-title":"Stat Med"},{"key":"10.1016\/j.jtha.2025.11.024_bib12","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/bimj.202000001","article-title":"Correcting the bias of the net benefit estimator due to right-censored observations","volume":"63","author":"P\u00e9ron","year":"2021","journal-title":"Biom J"},{"key":"10.1016\/j.jtha.2025.11.024_bib13","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1093\/eurheartj\/ehae647","article-title":"The win ratio in cardiology trials: lessons learnt, new developments, and wise future use","volume":"45","author":"Pocock","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.11.024_bib14","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/10543406.2020.1757690","article-title":"The use of the win odds in the design of non-inferiority clinical trials","volume":"30","author":"Peng","year":"2020","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.jtha.2025.11.024_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/CIRCULATIONAHA.124.072364","article-title":"Large-bore mechanical thrombectomy versus catheter-directed thrombolysis in the management of intermediate-risk pulmonary embolism: primary results of the PEERLESS randomized controlled trial","volume":"151","author":"Jaber","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.11.024_bib16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ahj.2023.09.002","article-title":"Randomized controlled trial of mechanical thrombectomy vs catheter-directed thrombolysis for acute hemodynamically stable pulmonary embolism: rationale and design of the PEERLESS study","volume":"266","author":"Gonsalves","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.jtha.2025.11.024_bib17","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1161\/STROKEAHA.121.034480","article-title":"Standardized nomenclature for modified Rankin scale global disability outcomes: consensus recommendations from stroke therapy academic industry roundtable XI","volume":"52","author":"Saver","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.11.024_bib18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic anticoagulation with heparin in critically ill patients with Covid-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.024_bib19","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.11.024_bib20","series-title":"Multiple endpoints in clinical trials - guidance for industry","year":"2024"},{"key":"10.1016\/j.jtha.2025.11.024_bib21","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/S2468-2667(22)00006-8","article-title":"Relative contribution of trends in myocardial infarction event rates and case fatality to declines in mortality: an international comparative study of 1\u00b795 million events in 80\u00b74 million people in four countries","volume":"7","author":"Camacho","year":"2022","journal-title":"Lancet Public Health"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625009043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625009043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:03:07Z","timestamp":1781452987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625009043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1538783625009043"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.024","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The win ratio for evaluating edoxaban vs dalteparin for cancer-associated venous thromboembolism: an analysis of the randomized Hokusai Venous Thromboembolism Cancer trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}